000 05868nam a2200421 c 4500
999 _c117979
_d117979
001 117979
003 ES-MaUEC
005 20230102113837.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191109s2019 si a o |||| 0|eng d
020 _a9789813297210
024 7 _a10.1007/978-981-32-9721-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC454
_b.F766 2019
245 0 0 _aFrontiers in Psychiatry
_bArtificial Intelligence, Precision Medicine, and Other Paradigm Shifts
_cedited by Yong-Ku Kim.
250 _aFirst edition
264 1 _aSingapore
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XI, 641 páginas)
_b21 ilustraciones, 17 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aAdvances in Experimental Medicine and Biology
_x0065-2598
_v1192
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aPart 1. Challenges and Strategies -- Chapter 1. Challenges of Big Data and Discovery Sciences in Psychiatry -- Chapter 2. Challenges and Strategies for the Classification of Psychiatric Disorders -- Chapter 3. Genetic markers of Alzheimer's disease -- Chapter 4. Genetic markers in Psychiatry -- Chapter 5. Recent advances in Neuroimaging of Small Vessel Disease in Late-life Depression -- Part 2. Advances in artificial intelligence technologies -- Chapter 6. Artificial Intelligence in Psychiatry -- Chapter 7. Machine Learning in Neural Networks: Clinical Opportunity of a Paradigm Shift -- Chapter 8. Imaging Connectomics: A new insights for understanding brain diseases -- Chapter 9. Development of Neuroimaging-based Biomarkers in Psychiatry: back to the future -- Part 3. Research methods for Precision Medicine -- Chapter 10. Precision Psychiatry: Biomarker guided Tailored Therapy for Effective Treatment and Prevention -- Chapter 11. Women Psychiatry: Do we need a New Paradigm? -- Chapter 12. CHILD PSYCHIATRY: What We Know and What We Don't Know on Mood Disorders -- Chapter 13. The frontiers of suicide -A global threat or global phenomenon -- Part 4. Ongoing paradigm shifts -- Chapter 14. Animal Research in psychiatry: a paradigm shift -- Chapter 15. Modeling psychiatric diseases with induced pluripotent stem (iPS) cells -- Chapter 16. Paradigm Shift in Psychopharmacology and Psychotherapy Research -- Chapter 17. More integrated Bio-Psycho-Social approach to Psychiatric Disorders -- Chapter 18. Early Identification of Psychiatric Disorders: do we need a paradigm shift? -- Part 5. New Theoretical frameworks for Research -- Chapter 19. Theoretical psychiatry: Missing link between academic and clinical psychiatry for further scientific and professional maturation of psychiatry -- Chapter 20. Theoretical psychiatry and transdisciplinary integrative approach: Stepping stones to precision and person-centered psychiatry -- Chapter 21. Developmental Psychopathology: Application to Psychiatry -- Chapter 22. Emotion: Concepts and Dysfunctions in Neuropsychiatric Research -- Chapter 23. Resilience: A Psychopathological Construct for Psychiatric Disorders -- Chapter 24. Inflammation for psychiatric disorders: Fact or Hypothesis -- Chapter 25. Smart Healthcare System and Precision Medicine: through the Brain Mechanisms of the Smartphone and Internet Game Addiction -- Part 6. Novel interventions -- Chapter 26. Telomere-telomerase system in psychiatric disorders and it's role in treatment -- Chapter 27. Neuromodulation on Cognitive Control of Emotion: a paradigm shift -- Chapter 28. Psychobiotics: A paradigm shift in Psychopharmacology -- Chapter 29. Digital Interventions for Mental Disorders: Key Features, Efficacy, and Potential for Artificial Intelligence Applications -- Chapter 30. Cognitive behavioral therapy for insomnia using internet, mobile application, and wearable devices.
520 3 _aThis book reviews key recent advances and new frontiers within psychiatric research and clinical practice. These advances either represent or are enabling paradigm shifts in the discipline and are influencing how we observe, derive and test hypotheses, and intervene. Progress in information technology is allowing the collection of scattered, fragmented data and the discovery of hidden meanings from stored data, and the impacts on psychiatry are fully explored. Detailed attention is also paid to the applications of artificial intelligence, machine learning, and data science technology in psychiatry and to their role in the development of new hypotheses, which in turn promise to lead to new discoveries and treatments. Emerging research methods for precision medicine are discussed, as are a variety of novel theoretical frameworks for research, such as theoretical psychiatry, the developmental approach to the definition of psychopathology, and the theory of constructed emotion. The concluding section considers novel interventions and treatment avenues, including psychobiotics, the use of neuromodulation to augment cognitive control of emotion, and the role of the telomere-telomerase system in psychopharmacological interventions.
988 _aPrimersemestre_2020_BiomedLife
650 7 _2embne
_aPsiquiatría
_9139041
700 1 _aKim, Yong-Ku
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789813297203
776 0 8 _iPrinted edition:
_z9789813297227
776 0 8 _iPrinted edition:
_z9789813297234
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-32-9721-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0